Indivior plc (INDV) ORD USD0.5

Sell:920.00pBuy:924.00pNo change

Prices delayed by at least 15 minutes
Sell:920.00p
Buy:924.00p
Change:No change
Prices delayed by at least 15 minutes
Sell:920.00p
Buy:924.00p
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Indivior PLC is a pharmaceutical company. The Company is engaged in developing medicines to treat substance use disorders (SUD), serious mental illnesses, and opioid overdose. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder, and co-morbidities, including schizophrenia. Its core products include SUBLOCADE (buprenorphine extended release) monthly injection; SUBOXONE Film (buprenorphine and naloxone sublingual film); SUBOXONE Tablet (buprenorphine and naloxone sublingual tablets), and SUBUTEX Tablet (buprenorphine sublingual tablets). Its products for the treatment of opioid disorders (OUD) are OPVEE (nalmefene) nasal spray for opioid overdose reversal, and PERSERIS (risperidone) extended-release injectable suspension for the treatment of schizophrenia in adults in the United States. Its portfolio of products is available in 37 countries.

Key people

Mark Crossley
Chief Executive Officer, Executive Director
Jon Fogle
Chief Human Resource Officer
Christian Heidbreder
Chief Scientific Officer
Cynthia Cetani
Chief Integrity and Compliance Officer
Jeffrey W. Burris
Chief Legal Officer
Vishal Kalia
Chief Impact and Strategy Officer
Richard Simkin
Chief Commercial Officer
Hillel West
Chief Manufacturing and Supply Officer
Kathryn Barbara Hudson
Company Secretary
David E. Wheadon
Non-Executive Independent Chairman of the Board
Jerome J. Lande
Non-Executive Director
Peter Bains
Non-Executive Independent Director
Joseph J. Ciaffoni
Non-Executive Independent Director
Keith Humphreys
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    INDV
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB00BN4HT335
  • Market cap
    £1.14bn
  • Employees
    1,051
  • Shares in issue
    124.14m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.